Cutler Group LP Macrogenics Inc Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 07, 2020	SELL	$4.28 - $12.11 $428 - $1,211	-100 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$7.95 - $12.27 $2,385 - $3,681	-300 Reduced 75.0%	100 $0
Q3 2019 Oct 28, 2019	SELL	$12.44 - $17.48 $252,532 - $354,844	-20,300 Reduced 98.07%	400 $0
Q1 2019 May 10, 2019	BUY	$11.11 - $25.6 $229,977 - $529,920	20,700 New	20,700 $10,000
Q3 2018 Nov 07, 2018	SELL	$19.26 - $23.46 $11,556 - $14,076	-600 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$19.78 - $24.67 $5,934 - $7,401	-300 Reduced 33.33%	600 $0
Q1 2018 May 11, 2018	SELL	$18.89 - $32.46 $96,339 - $165,546	-5,100 Reduced 85.0%	900 $4,000
Q3 2017 Oct 17, 2017	BUY	$15.52 - $18.94 $93,120 - $113,640	6,000	6,000 $1,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $224M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.